Hepatocellular carcinoma patients are advantaged in the current Brazilian liver transplant allocation system. A competing risk analysis
Santiago RODRÍGUEZ, Alfeu de Medeiros FLECK JR, Marcos MUCENIC, Cláudio MARRONI, Ajacio BRANDÃO Background – In Brazil, the Model for End-Stage Liver Disease (MELD) score is used to prioritize patients for deceased donor liver transplantation (DDLT). Patients with hepatocellular carcinoma (HCC) receive standardized MELD exception points to account for their cancer risk of mortality, which…
Veja mais